Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Thiophanate Methyl SCHEMBL41622 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNAHPGDALOX15HSD17B10 | |
| Thiophanate Methyl SCHEMBL16537027 | 0.98 | ALDH1A1 (0.96) | ALDH1A1LMNAHPGDALOX15HSD17B10 | |
| Thiophanate Methyl SCHEMBL28315984 | 0.98 | ALDH1A1 (0.96) | ALDH1A1LMNAHPGDALOX15HSD17B10 | |
| SCHEMBL11677871 | 0.96 | ALDH1A1 (0.93) | ALDH1A1LMNAHPGDALOX15HSD17B10 | |
| SCHEMBL11676773 | 0.95 | ALDH1A1 (0.90) | ALDH1A1LMNAHPGDALOX15HSD17B10 | |
| SCHEMBL11677674 | 0.93 | ALDH1A1 (0.87) | ALDH1A1LMNAHPGDALOX15HSD17B10 | |
| SCHEMBL29376012 | 0.93 | ALDH1A1 (0.87) | ALDH1A1LMNAHPGDALOX15HSD17B10 | |
| SCHEMBL11796333 | 0.93 | ALDH1A1 (0.87) | ALDH1A1LMNAHPGDALOX15HSD17B10 | |
| SCHEMBL11804708 | 0.93 | ALDH1A1 (0.87) | ALDH1A1LMNAHPGDALOX15HSD17B10 | |
| SCHEMBL11677705 | 0.93 | ALDH1A1 (0.87) | ALDH1A1LMNAHPGDALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250176549-A1 | FUNGICIDAL COMBINATIONS, MIXTURES AND COMPOSITIONS AND USES THEREOF | ADAMA MAKHTESHIM LTD. (IL) | 2025-06-05 | — | — | US | claimed |
| EP-4486126-A1 | FUNGICIDAL COMBINATIONS, MIXTURES AND COMPOSITIONS AND USES THEREOF | ADAMA MAKHTESHIM LTD. (IL) | 2025-01-08 | — | — | EP | claimed |
| EP-4255175-A1 | PREDICTIVE PESTICIDE RESISTANCE MAP GENERATION AND USE | Pioneer Hi-Bred International, Inc. (US) | 2023-10-11 | — | — | EP | claimed |
| WO-2023166485-A1 | FUNGICIDAL COMBINATIONS, MIXTURES AND COMPOSITIONS AND USES THEREOF | ADAMA MAKHTESHIM LTD. (IL) | 2023-09-07 | — | — | WO | claimed |
| US-20230150228-A1 | ROLL-UP THERMAL BARRIER | RYTEC CORP (US) | 2023-05-18 | — | — | US | claimed |
| EP-2453739-B2 | A PROCESS FOR PREPARING AN AQUEOUS SUSPENSION OF AN ORGANIC PESTICIDE COMPOUND | BASF SE (DE) | 2023-03-01 | — | — | EP | claimed |
| WO-2022136003-A1 | MIXTURES AND COMPOSITIONS COMPRISING FUSARICIDIN A, FUSARICIDIN B AND FUNGICIDES | BASF SE (DE) | 2022-06-30 | — | — | WO | claimed |
| WO-2022099169-A1 | PREDICTIVE PESTICIDE RESISTANCE MAP GENERATION AND USE | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2022-05-12 | — | — | WO | claimed |
| EP-4735569-A1 | ALKYL SULFONIC ACID COMPOSITIONS COMPRISING SOLVENT USEFUL IN DESCALING APPLICATIONS | Jelmar LLC (US) | 2026-05-06 | — | — | EP | disclosed |
| WO-2026087745-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-30 | — | — | WO | disclosed |
| US-20260116872-A1 | THIOPHENE BASED APYRASE INHIBITORS | TEXAS CROP SCIENCE INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260116873-A1 | APYRASE INHIBITORS | TEXAS CROP SCIENCE INC (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4704819-A1 | NANOPARTICLE COMPOSITION FOR OXYGEN DELIVERY | Swaza Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| WO-2026044006-A1 | MODIFIED STARCH COMPOUNDS AND USES THEREOF | ISP INVESTMENTS LLC (US) | 2026-02-26 | — | — | WO | disclosed |
| WO-2022097598-A1 | BENZOXAZINE COMPOUND-CONTAINING COMPOSITION, CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF | 本州化学工業株式会社 | 2022-05-12 | — | — | WO | disclosed |
| EP-3993626-A1 | HERBICIDAL COMPOSITIONS | Bayer Aktiengesellschaft (DE) | 2022-05-11 | — | — | EP | disclosed |
| EP-3615540-B1 | CONDENSED BICYCLIC HETEROCYCLE DERIVATIVES AS PESTICIDES | BAYER AG (DE) | 2022-04-27 | — | — | EP | disclosed |
| WO-2022053453-A1 | AZOLE CARBOXAMIDE AS PEST CONTROL AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2022-03-17 | — | — | WO | disclosed |
| CN-109553520-B | Production process of gold potassium citrate | 泰州市欣港电子材料有限公司 | 2022-02-22 | — | — | CN | disclosed |
| EP-3952650-A1 | FUNGICIDE COMPOSITION FOR CONTROLLING ZYMOSEPTORIA INFECTION IN PLANT | UPL Corporation Limited (MU) | 2022-02-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260116873-A1 | APYRASE INHIBITORS | APEH, AP3M1, SRR | ALDH1A1 2831/4885LMNA 4349/4885HPGD 2400/4885 |
| US-20260116872-A1 | THIOPHENE BASED APYRASE INHIBITORS | SRR, APEH, OSR1 | ALDH1A1 2701/4885LMNA 4794/4885HPGD 3033/4885 |
| US-20250176549-A1 | FUNGICIDAL COMBINATIONS, MIXTURES AND COMPOSITIONS AND USES THEREOF | THRB, OSBP, TPI1 | ALDH1A1 2667/4885LMNA 4213/4885HPGD 4084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.